1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cancer Medication Market Size by Type: 2016 VS 2021 VS 2027 1.2.2 Antimetabolite 1.2.3 Alkaloid Drugs 1.2.4 Hormone 1.2.5 Targeted Drug 1.2.6 Platinum-based Drugs 1.2.7 Other 1.3 Market by Application 1.3.1 Global Cancer Medication Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Blood Cancer 1.3.3 Breast Cancer 1.3.4 Castrointestinal Cancer 1.3.5 Prostate Cancer 1.3.6 Respiratory/Lung Cancer 1.3.7 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trend 2.1 Global Cancer Medication Market Perspective (2016-2027) 2.2 Global Cancer Medication Growth Trends by Regions 2.2.1 Cancer Medication Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Cancer Medication Historic Market Size by Regions (2016-2021) 2.2.3 Cancer Medication Forecasted Market Size by Regions (2022-2027) 2.3 Industry Trends and Growth Strategy 2.3.1 Cancer Medication Industry Trends 2.3.2 Cancer Medication Market Drivers 2.3.3 Cancer Medication Market Challenges 2.3.4 Cancer Medication Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cancer Medication Players by Market Size 3.1.1 Players Covered: Ranking by Cancer Medication Revenue 3.1.2 Global Top Cancer Medication Players by Revenue (2016-2021) 3.1.3 Global Cancer Medication Revenue Market Share by Players (2016-2021) 3.1.4 Global Cancer Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Cancer Medication Market Concentration Ratio 3.2.1 Global Cancer Medication Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 5 and Top 10 Players by Cancer Medication Revenue in 2020 3.3 Cancer Medication Key Players Head office and Area Served 3.4 Key Players Cancer Medication Product Solution and Service 3.5 Date of Enter into Cancer Medication Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Global Cancer Medication Breakdown Data by Type (2016-2027) 4.1 Global Cancer Medication Historic Market Size by Type (2016-2021) 4.2 Global Cancer Medication Forecasted Market Size by Type (2022-2027) 5 Global Cancer Medication Breakdown Data by Application (2016-2027) 5.1 Global Cancer Medication Historic Market Size by Application (2016-2021) 5.2 Cancer Medication Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Cancer Medication Market Size (2016-2027) 6.2 Key Cancer Medication Players Market Share in North America (2020-2021) 6.3 North America Cancer Medication Market Size by Country 6.3.1 North America Cancer Medication Market Size by Country (2016-2021) 6.3.2 North America Cancer Medication Market Size Forecast by Country (2022-2027) 6.4 U.S. Market Size Analysis 6.4.1 U.S. Cancer Medication Market Size (2016-2027) 6.4.2 U.S. Cancer Medication Market Size by Type (2016-2027) 6.4.3 U.S. Cancer Medication Market Size by Application (2016-2027) 6.5 Canada Market Size Analysis 6.5.1 Canada Cancer Medication Market Size (2016-2027) 6.5.2 Canada Cancer Medication Market Size by Type (2016-2027) 6.5.3 Canada Cancer Medication Market Size by Application (2016-2027) 7 Europe 7.1 Europe Cancer Medication Market Size (2016-2027) 7.2 Key Cancer Medication Players Market Share in Europe (2020-2021) 7.3 Europe Cancer Medication Market Size by Country 7.3.1 Europe Cancer Medication Market Size by Country (2016-2021) 7.3.2 Europe Cancer Medication Market Size Forecast by Country (2022-2027) 7.4 Germany Market Size Analysis 7.4.1 Germany Cancer Medication Market Size (2016-2027) 7.4.2 Germany Cancer Medication Market Size by Type (2016-2027) 7.4.3 Germany Cancer Medication Market Size by Application (2016-2027) 7.5 France Market Size Analysis 7.5.1 France Cancer Medication Market Size (2016-2027) 7.5.2 France Cancer Medication Market Size by Type (2016-2027) 7.5.3 France Cancer Medication Market Size by Application (2016-2027) 7.6 U.K. Market Size Analysis 7.6.1 U.K. Cancer Medication Market Size (2016-2027) 7.6.2 U.K. Cancer Medication Market Size by Type (2016-2027) 7.6.3 U.K. Cancer Medication Market Size by Application (2016-2027) 7.7 Italy Market Size Analysis 7.7.1 Italy Cancer Medication Market Size (2016-2027) 7.7.2 Italy Cancer Medication Market Size by Type (2016-2027) 7.7.3 Italy Cancer Medication Market Size by Application (2016-2027) 7.8 Russia Market Size Analysis 7.8.1 Russia Cancer Medication Market Size (2016-2027) 7.8.2 Russia Cancer Medication Market Size by Type (2016-2027) 7.8.3 Russia Cancer Medication Market Size by Application (2016-2027) 8 Asia-Pacific 8.1 Asia-Pacific Cancer Medication Market Size (2016-2027) 8.2 Key Cancer Medication Players Market Share in Asia-Pacific (2020-2021) 8.3 Asia-Pacific Cancer Medication Market Size by Region 8.3.1 Asia-Pacific Cancer Medication Market Size by Region (2016-2021) 8.3.2 Asia-Pacific Cancer Medication Market Size Forecast by Region (2022-2027) 8.4 China Market Size Analysis 8.4.1 China Cancer Medication Market Size (2016-2027) 8.4.2 China Cancer Medication Market Size by Type (2016-2027) 8.4.3 China Cancer Medication Market Size by Application (2016-2027) 8.5 Japan Market Size Analysis 8.5.1 Japan Cancer Medication Market Size (2016-2027) 8.5.2 Japan Cancer Medication Market Size by Type (2016-2027) 8.5.3 Japan Cancer Medication Market Size by Application (2016-2027) 8.6 South Korea Market Size Analysis 8.6.1 South Korea Cancer Medication Market Size (2016-2027) 8.6.2 South Korea Cancer Medication Market Size by Type (2016-2027) 8.6.3 South Korea Cancer Medication Market Size by Application (2016-2027) 8.7 India Market Size Analysis 8.7.1 India Cancer Medication Market Size (2016-2027) 8.7.2 India Cancer Medication Market Size by Type (2016-2027) 8.7.3 India Cancer Medication Market Size by Application (2016-2027) 8.8 Australia Market Size Analysis 8.8.1 Australia Cancer Medication Market Size (2016-2027) 8.8.2 Australia Cancer Medication Market Size by Type (2016-2027) 8.8.3 Australia Cancer Medication Market Size by Application (2016-2027) 8.9 Taiwan Market Size Analysis 8.9.1 Taiwan Cancer Medication Market Size (2016-2027) 8.9.2 Taiwan Cancer Medication Market Size by Type (2016-2027) 8.9.3 Taiwan Cancer Medication Market Size by Application (2016-2027) 8.10 Indonesia Market Size Analysis 8.10.1 Indonesia Cancer Medication Market Size (2016-2027) 8.10.2 Indonesia Cancer Medication Market Size by Type (2016-2027) 8.10.3 Indonesia Cancer Medication Market Size by Application (2016-2027) 8.11 Thailand Market Size Analysis 8.11.1 Thailand Cancer Medication Market Size (2016-2027) 8.11.2 Thailand Cancer Medication Market Size by Type (2016-2027) 8.11.3 Thailand Cancer Medication Market Size by Application (2016-2027) 8.12 Malaysia Market Size Analysis 8.12.1 Malaysia Cancer Medication Market Size (2016-2027) 8.12.2 Malaysia Cancer Medication Market Size by Type (2016-2027) 8.12.3 Malaysia Cancer Medication Market Size by Application (2016-2027) 8.13 Philippines Market Size Analysis 8.13.1 Philippines Cancer Medication Market Size (2016-2027) 8.13.2 Philippines Cancer Medication Market Size by Type (2016-2027) 8.13.3 Philippines Cancer Medication Market Size by Application (2016-2027) 8.14 Vietnam Market Size Analysis 8.14.1 Vietnam Cancer Medication Market Size (2016-2027) 8.14.2 Vietnam Cancer Medication Market Size by Type (2016-2027) 8.14.3 Vietnam Cancer Medication Market Size by Application (2016-2027) 9 Latin America 9.1 Latin America Cancer Medication Market Size (2016-2027) 9.2 Key Cancer Medication Players Market Share in Latin America (2020-2021) 9.3 Latin America Cancer Medication Market Size by Country 9.3.1 Latin America Cancer Medication Market Size by Country (2016-2021) 9.3.2 Latin America Cancer Medication Market Size Forecast by Country (2022-2027) 9.4 Mexico Market Size Analysis 9.4.1 Mexico Cancer Medication Market Size (2016-2027) 9.4.2 Mexico Cancer Medication Market Size by Type (2016-2027) 9.4.3 Mexico Cancer Medication Market Size by Application (2016-2027) 9.5 Brazil Market Size Analysis 9.5.1 Brazil Cancer Medication Market Size (2016-2027) 9.5.2 Brazil Cancer Medication Market Size by Type (2016-2027) 9.5.3 Brazil Cancer Medication Market Size by Application (2016-2027) 9.6 Argentina Market Size Analysis 9.6.1 Argentina Cancer Medication Market Size (2016-2027) 9.6.2 Argentina Cancer Medication Market Size by Type (2016-2027) 9.6.3 Argentina Cancer Medication Market Size by Application (2016-2027) 10 Middle East & Africa 10.1 Middle East & Africa Cancer Medication Market Size (2016-2027) 10.2 Key Cancer Medication Players Market Share in Middle East & Africa (2020-2021) 10.3 Middle East & Africa Cancer Medication Market Size by Country 10.3.1 Middle East & Africa Cancer Medication Market Size by Country (2016-2021) 10.3.2 Middle East & Africa Cancer Medication Market Size Forecast by Country (2022-2027) 10.4 Turkey Market Size Analysis 10.4.1 Turkey Cancer Medication Market Size (2016-2027) 10.4.2 Turkey Cancer Medication Market Size by Type (2016-2027) 10.4.3 Turkey Cancer Medication Market Size by Application (2016-2027) 10.5 Saudi Arabia Market Size Analysis 10.5.1 Saudi Arabia Cancer Medication Market Size (2016-2027) 10.5.2 Saudi Arabia Cancer Medication Market Size by Type (2016-2027) 10.5.3 Saudi Arabia Cancer Medication Market Size by Application (2016-2027) 10.6 UAE Market Size Analysis 10.6.1 UAE Cancer Medication Market Size (2016-2027) 10.6.2 UAE Cancer Medication Market Size by Type (2016-2027) 10.6.3 UAE Cancer Medication Market Size by Application (2016-2027) 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview and Its Total Revenue 11.1.3 Roche Cancer Medication Introduction 11.1.4 Roche Revenue in Cancer Medication Business (2016-2021) 11.1.5 Roche Recent Development 11.2 HENGRUI 11.2.1 HENGRUI Company Details 11.2.2 HENGRUI Business Overview and Its Total Revenue 11.2.3 HENGRUI Cancer Medication Introduction 11.2.4 HENGRUI Revenue in Cancer Medication Business (2016-2021) 11.2.5 HENGRUI Recent Development 11.3 AstraZeneca 11.3.1 AstraZeneca Company Details 11.3.2 AstraZeneca Business Overview and Its Total Revenue 11.3.3 AstraZeneca Cancer Medication Introduction 11.3.4 AstraZeneca Revenue in Cancer Medication Business (2016-2021) 11.3.5 AstraZeneca Recent Development 11.4 QILU 11.4.1 QILU Company Details 11.4.2 QILU Business Overview and Its Total Revenue 11.4.3 QILU Cancer Medication Introduction 11.4.4 QILU Revenue in Cancer Medication Business (2016-2021) 11.4.5 QILU Recent Development 11.5 Sanofi 11.5.1 Sanofi Company Details 11.5.2 Sanofi Business Overview and Its Total Revenue 11.5.3 Sanofi Cancer Medication Introduction 11.5.4 Sanofi Revenue in Cancer Medication Business (2016-2021) 11.5.5 Sanofi Recent Development 11.6 HANSOH 11.6.1 HANSOH Company Details 11.6.2 HANSOH Business Overview and Its Total Revenue 11.6.3 HANSOH Cancer Medication Introduction 11.6.4 HANSOH Revenue in Cancer Medication Business (2016-2021) 11.6.5 HANSOH Recent Development 11.7 LUYE 11.7.1 LUYE Company Details 11.7.2 LUYE Business Overview and Its Total Revenue 11.7.3 LUYE Cancer Medication Introduction 11.7.4 LUYE Revenue in Cancer Medication Business (2016-2021) 11.7.5 LUYE Recent Development 11.8 Novartis 11.8.1 Novartis Company Details 11.8.2 Novartis Business Overview and Its Total Revenue 11.8.3 Novartis Cancer Medication Introduction 11.8.4 Novartis Revenue in Cancer Medication Business (2016-2021) 11.8.5 Novartis Recent Development 11.9 GuiZhou YiBai 11.9.1 GuiZhou YiBai Company Details 11.9.2 GuiZhou YiBai Business Overview and Its Total Revenue 11.9.3 GuiZhou YiBai Cancer Medication Introduction 11.9.4 GuiZhou YiBai Revenue in Cancer Medication Business (2016-2021) 11.9.5 GuiZhou YiBai Recent Development 11.10 Lunan 11.10.1 Lunan Company Details 11.10.2 Lunan Business Overview and Its Total Revenue 11.10.3 Lunan Cancer Medication Introduction 11.10.4 Lunan Revenue in Cancer Medication Business (2016-2021) 11.10.5 Lunan Recent Development 11.11 Eli Lilly and Company 11.11.1 Eli Lilly and Company Company Details 11.11.2 Eli Lilly and Company Business Overview and Its Total Revenue 11.11.3 Eli Lilly and Company Cancer Medication Introduction 11.11.4 Eli Lilly and Company Revenue in Cancer Medication Business (2016-2021) 11.11.5 Eli Lilly and Company Recent Development 12 Analyst's Viewpoints/Conclusion 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cancer Medication Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027 Table 2. Key Players of Antimetabolite Table 3. Key Players of Alkaloid Drugs Table 4. Key Players of Hormone Table 5. Key Players of Targeted Drug Table 6. Key Players of Platinum-based Drugs Table 7. Key Players of Other Table 8. Global Cancer Medication Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Cancer Medication Market Size by Region (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Cancer Medication Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global Cancer Medication Market Share by Regions (2016-2021) Table 12. Global Cancer Medication Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global Cancer Medication Market Share by Regions (2022-2027) Table 14. Cancer Medication Market Trends Table 15. Cancer Medication Market Drivers Table 16. Cancer Medication Market Challenges Table 17. Cancer Medication Market Restraints Table 18. Ranking of Global Top Cancer Medication Manufacturers by Revenue (US$ Million) in 2020 Table 19. Global Cancer Medication Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Cancer Medication Market Share by Players (2016-2021) Table 21. Global Top Cancer Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Medication as of 2020) Table 22. Global 5 Largest Players Market Share by Cancer Medication Revenue (CR5 and HHI) (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Cancer Medication Product Solution and Service Table 25. Date of Enter into Cancer Medication Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Cancer Medication Market Size by Type (2016-2021) & (US$ Million) Table 28. Global Cancer Medication Revenue Market Share by Type (2016-2021) Table 29. Global Cancer Medication Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 30. Global Cancer Medication Revenue Market Share by Type (2022-2027) Table 31. Global Cancer Medication Market Size by Application (2016-2021) & (US$ Million) Table 32. Global Cancer Medication Revenue Market Share by Application (2016-2021) Table 33. Global Cancer Medication Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 34. Global Cancer Medication Revenue Market Share by Application (2022-2027) Table 35. Key Players Cancer Medication Revenue in North America (2020-2021) (US$ Million) Table 36. North America Cancer Medication Market Size by Countries (2016-2021) & (US$ Million) Table 37. North America Cancer Medication Market Size Share by Countries (2016-2021) Table 38. North America Cancer Medication Market Size by Countries (2022-2027) & (US$ Million) Table 39. North America Cancer Medication Market Size Share by Countries (2022-2027) Table 40. Cancer Medication Market Size (US$ Million) in U.S., Breakdown by Type (2016-2021) Table 41. Cancer Medication Market Size (US$ Million) in U.S., Breakdown by Type (2022-2027) Table 42. Cancer Medication Market Size (US$ Million) in U.S., Breakdown by Application (2016-2021) Table 43. Cancer Medication Market Size (US$ Million) in U.S., Breakdown by Application (2022-2027) Table 44. Cancer Medication Market Size (US$ Million) in Canada, Breakdown by Type (2016-2021) Table 45. Cancer Medication Market Size (US$ Million) in Canada, Breakdown by Type (2022-2027) Table 46. Cancer Medication Market Size (US$ Million) in Canada, Breakdown by Application (2016-2021) Table 47. Cancer Medication Market Size (US$ Million) in Canada, Breakdown by Application (2022-2027) Table 48. Key Players Cancer Medication Revenue in Europe (2020-2021) (US$ Million) Table 49. Europe Cancer Medication Market Size by Countries (2016-2021) & (US$ Million) Table 50. Europe Cancer Medication Market Size Share by Countries (2016-2021) Table 51. Europe Cancer Medication Market Size by Countries (2022-2027) & (US$ Million) Table 52. Europe Cancer Medication Market Size Share by Countries (2022-2027) Table 53. Cancer Medication Market Size (US$ Million) in Germany, Breakdown by Type (2016-2021) Table 54. Cancer Medication Market Size (US$ Million) in Germany, Breakdown by Type (2022-2027) Table 55. Cancer Medication Market Size (US$ Million) in Germany, Breakdown by Application (2016-2021) Table 56. Cancer Medication Market Size (US$ Million) in Germany, Breakdown by Application (2022-2027) Table 57. Cancer Medication Market Size (US$ Million) in France, Breakdown by Type (2016-2021) Table 58. Cancer Medication Market Size (US$ Million) in France, Breakdown by Type (2022-2027) Table 59. Cancer Medication Market Size (US$ Million) in France, Breakdown by Application (2016-2021) Table 60. Cancer Medication Market Size (US$ Million) in France, Breakdown by Application (2022-2027) Table 61. Cancer Medication Market Size (US$ Million) in U.K., Breakdown by Type (2016-2021) Table 62. Cancer Medication Market Size (US$ Million) in U.K., Breakdown by Type (2022-2027) Table 63. Cancer Medication Market Size (US$ Million) in U.K., Breakdown by Application (2016-2021) Table 64. Cancer Medication Market Size (US$ Million) in U.K., Breakdown by Application (2022-2027) Table 65. Cancer Medication Market Size (US$ Million) in Italy, Breakdown by Type (2016-2021) Table 66. Cancer Medication Market Size (US$ Million) in Italy, Breakdown by Type (2022-2027) Table 67. Cancer Medication Market Size (US$ Million) in Italy, Breakdown by Application (2016-2021) Table 68. Cancer Medication Market Size (US$ Million) in Italy, Breakdown by Application (2022-2027) Table 69. Cancer Medication Market Size (US$ Million) in Russia, Breakdown by Type (2016-2021) Table 70. Cancer Medication Market Size (US$ Million) in Russia, Breakdown by Type (2022-2027) Table 71. Cancer Medication Market Size (US$ Million) in Russia, Breakdown by Application (2016-2021) Table 72. Cancer Medication Market Size (US$ Million) in Russia, Breakdown by Application (2022-2027) Table 73. Key Players Cancer Medication Revenue in Asia-Pacific (2020-2021) (US$ Million) Table 74. Asia-Pacific Cancer Medication Market Size by Regions (2016-2021) & (US$ Million) Table 75. Asia-Pacific Cancer Medication Market Size by Regions (2022-2027) & (US$ Million) Table 76. Cancer Medication Market Size (US$ Million) in China, Breakdown by Type (2016-2021) Table 77. Cancer Medication Market Size (US$ Million) in China, Breakdown by Type (2022-2027) Table 78. Cancer Medication Market Size (US$ Million) in China, Breakdown by Application (2016-2021) Table 79. Cancer Medication Market Size (US$ Million) in China, Breakdown by Application (2022-2027) Table 80. Cancer Medication Market Size (US$ Million) in Japan, Breakdown by Type (2016-2021) Table 81. Cancer Medication Market Size (US$ Million) in Japan, Breakdown by Type (2022-2027) Table 82. Cancer Medication Market Size (US$ Million) in Japan, Breakdown by Application (2016-2021) Table 83. Cancer Medication Market Size (US$ Million) in Japan, Breakdown by Application (2022-2027) Table 84. Cancer Medication Market Size (US$ Million) in South Korea, Breakdown by Type (2016-2021) Table 85. Cancer Medication Market Size (US$ Million) in South Korea, Breakdown by Type (2022-2027) Table 86. Cancer Medication Market Size (US$ Million) in South Korea, Breakdown by Application (2016-2021) Table 87. Cancer Medication Market Size (US$ Million) in South Korea, Breakdown by Application (2022-2027) Table 88. Cancer Medication Market Size (US$ Million) in India, Breakdown by Type (2016-2021) Table 89. Cancer Medication Market Size (US$ Million) in India, Breakdown by Type (2022-2027) Table 90. Cancer Medication Market Size (US$ Million) in India, Breakdown by Application (2016-2021) Table 91. Cancer Medication Market Size (US$ Million) in India, Breakdown by Application (2022-2027) Table 92. Cancer Medication Market Size (US$ Million) in Australia, Breakdown by Type (2016-2021) Table 93. Cancer Medication Market Size (US$ Million) in Australia, Breakdown by Type (2022-2027) Table 94. Cancer Medication Market Size (US$ Million) in Australia, Breakdown by Application (2016-2021) Table 95. Cancer Medication Market Size (US$ Million) in Australia, Breakdown by Application (2022-2027) Table 96. Cancer Medication Market Size (US$ Million) in Taiwan, Breakdown by Type (2016-2021) Table 97. Cancer Medication Market Size (US$ Million) in Taiwan, Breakdown by Type (2022-2027) Table 98. Cancer Medication Market Size (US$ Million) in Taiwan, Breakdown by Application (2016-2021) Table 99. Cancer Medication Market Size (US$ Million) in Taiwan, Breakdown by Application (2022-2027) Table 100. Cancer Medication Market Size (US$ Million) in Indonesia, Breakdown by Type (2016-2021) Table 101. Cancer Medication Market Size (US$ Million) in Indonesia, Breakdown by Type (2022-2027) Table 102. Cancer Medication Market Size (US$ Million) in Indonesia, Breakdown by Application (2016-2021) Table 103. Cancer Medication Market Size (US$ Million) in Indonesia, Breakdown by Application (2022-2027) Table 104. Key Players Cancer Medication Revenue in Latin America (2020-2021) (US$ Million) Table 105. Latin America Cancer Medication Market Size by Countries (2016-2021) & (US$ Million) Table 106. Latin America Cancer Medication Market Size by Countries (2022-2027) & (US$ Million) Table 107. Cancer Medication Market Size (US$ Million) in Mexico, Breakdown by Type (2016-2021) Table 108. Cancer Medication Market Size (US$ Million) in Mexico, Breakdown by Type (2022-2027) Table 109. Cancer Medication Market Size (US$ Million) in Mexico, Breakdown by Application (2016-2021) Table 110. Cancer Medication Market Size (US$ Million) in Mexico, Breakdown by Application (2022-2027) Table 111. Cancer Medication Market Size (US$ Million) in Brazil, Breakdown by Type (2016-2021) Table 112. Cancer Medication Market Size (US$ Million) in Brazil, Breakdown by Type (2022-2027) Table 113. Cancer Medication Market Size (US$ Million) in Brazil, Breakdown by Application (2016-2021) Table 114. Cancer Medication Market Size (US$ Million) in Brazil, Breakdown by Application (2022-2027) Table 115. Cancer Medication Market Size (US$ Million) in Argentina, Breakdown by Type (2016-2021) Table 116. Cancer Medication Market Size (US$ Million) in Argentina, Breakdown by Type (2022-2027) Table 117. Cancer Medication Market Size (US$ Million) in Argentina, Breakdown by Application (2016-2021) Table 118. Cancer Medication Market Size (US$ Million) in Argentina, Breakdown by Application (2022-2027) Table 119. Key Players Cancer Medication Revenue in Middle East & Africa (2020-2021) (US$ Million) Table 120. Middle East & Africa Cancer Medication Market Size by Countries (2016-2021) & (US$ Million) Table 121. Middle East & Africa Cancer Medication Market Size by Countries (2022-2027) & (US$ Million) Table 122. Cancer Medication Market Size (US$ Million) in Turkey, Breakdown by Type (2016-2021) Table 123. Cancer Medication Market Size (US$ Million) in Turkey, Breakdown by Type (2022-2027) Table 124. Cancer Medication Market Size (US$ Million) in Turkey, Breakdown by Application (2016-2021) Table 125. Cancer Medication Market Size (US$ Million) in Turkey, Breakdown by Application (2022-2027) Table 126. Cancer Medication Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2016-2021) Table 127. Cancer Medication Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2022-2027) Table 128. Cancer Medication Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2016-2021) Table 129. Cancer Medication Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2022-2027) Table 130. Cancer Medication Market Size (US$ Million) in UAE, Breakdown by Type (2016-2021) Table 131. Cancer Medication Market Size (US$ Million) in UAE, Breakdown by Type (2022-2027) Table 132. Cancer Medication Market Size (US$ Million) in UAE, Breakdown by Application (2016-2021) Table 133. Cancer Medication Market Size (US$ Million) in UAE, Breakdown by Application (2022-2027) Table 134. Roche Company Details Table 135. Roche Business Overview Table 136. Roche Revenue in Cancer Medication Business (2016-2021) & (US$ Million) Table 137. Roche Cancer Medication Cancer Medication Product Table 138. Roche Recent Development Table 139. HENGRUI Company Details Table 140. HENGRUI Business Overview Table 141. HENGRUI Revenue in Cancer Medication Business (2016-2021) & (US$ Million) Table 142. HENGRUI Cancer Medication Product Table 143. HENGRUI Recent Development Table 144. AstraZeneca Company Details Table 145. AstraZeneca Business Overview Table 146. AstraZeneca Revenue in Cancer Medication Business (2016-2021) & (US$ Million) Table 147. AstraZeneca Cancer Medication Product Table 148. AstraZeneca Recent Development Table 149. QILU Company Details Table 150. QILU Business Overview Table 151. QILU Revenue in Cancer Medication Business (2016-2021) & (US$ Million) Table 152. QILU Cancer Medication Product Table 153. QILU Recent Development Table 154. Sanofi Company Details Table 155. Sanofi Business Overview Table 156. Sanofi Revenue in Cancer Medication Business (2016-2021) & (US$ Million) Table 157. Sanofi Cancer Medication Product Table 158. Sanofi Recent Development Table 159. HANSOH Company Details Table 160. HANSOH Business Overview Table 161. HANSOH Revenue in Cancer Medication Business (2016-2021) & (US$ Million) Table 162. HANSOH Cancer Medication Product Table 163. HANSOH Recent Development Table 164. LUYE Company Details Table 165. LUYE Business Overview Table 166. LUYE Revenue in Cancer Medication Business (2016-2021) & (US$ Million) Table 167. LUYE Cancer Medication Product Table 168. LUYE Recent Development Table 169. Novartis Company Details Table 170. Novartis Business Overview Table 171. Novartis Revenue in Cancer Medication Business (2016-2021) & (US$ Million) Table 172. Novartis Cancer Medication Product Table 173. Novartis Recent Development Table 174. GuiZhou YiBai Company Details Table 175. GuiZhou YiBai Business Overview Table 176. GuiZhou YiBai Revenue in Cancer Medication Business (2016-2021) & (US$ Million) Table 177. GuiZhou YiBai Cancer Medication Product Table 178. GuiZhou YiBai Recent Development Table 179. Lunan Company Details Table 180. Lunan Business Overview Table 181. Lunan Revenue in Cancer Medication Business (2016-2021) & (US$ Million) Table 182. Lunan Cancer Medication Product Table 183. Lunan Recent Development Table 184. Eli Lilly and Company Company Details Table 185. Eli Lilly and Company Business Overview Table 186. Eli Lilly and Company Revenue in Cancer Medication Business (2016-2021) & (US$ Million) Table 187. Eli Lilly and Company Cancer Medication Product Table 188. Eli Lilly and Company Recent Development Table 189. Research Programs/Design for This Report Table 190. Key Data Information from Secondary Sources Table 191. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Medication Market Share by Type: 2020 & 2027 Figure 2. Antimetabolite Features Figure 3. Alkaloid Drugs Features Figure 4. Hormone Features Figure 5. Targeted Drug Features Figure 6. Platinum-based Drugs Features Figure 7. Other Features Figure 8. Global Cancer Medication Market Share by Application: 2020 & 2027 Figure 9. Blood Cancer Case Studies Figure 10. Breast Cancer Case Studies Figure 11. Castrointestinal Cancer Case Studies Figure 12. Prostate Cancer Case Studies Figure 13. Respiratory/Lung Cancer Case Studies Figure 14. Other Case Studies Figure 15. Cancer Medication Report Years Considered Figure 16. Global Cancer Medication Market Share by Regions: 2016 VS 2021 VS 2027 Figure 17. Global Cancer Medication Market Size YoY Growth 2016-2027 (US$ Million) Figure 18. Global Cancer Medication Market Share by Regions (2022-2027) Figure 19. Global Cancer Medication Market Share by Players in 2020 Figure 20. Global Top Cancer Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Medication as of 2020) Figure 21. The Top 10 and 5 Players Market Share by Cancer Medication Revenue in 2020 Figure 22. North America Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. U.S. Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Germany Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. France Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. U.K. Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Italy Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Russia Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Asia-Pacific Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. China Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Japan Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. South Korea Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. India Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Australia Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Taiwan Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Indonesia Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Thailand Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Malaysia Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Philippines Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Vietnam Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Latin America Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Mexico Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Brazil Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Argentina Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Middle East & Africa Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Turkey Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Saudi Arabia Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. UAE Cancer Medication Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Roche HENGRUI AstraZeneca QILU Sanofi HANSOH LUYE Novartis GuiZhou YiBai Lunan Eli Lilly and Company